Succeed with Sirion – Cancer Immunotherapy

videosSIRION Biotech GmbH
September 22nd 2021

SIRION’s technologies were leveraged in Dr. Bianca Simon and her colleagues’ research showing potential in the growing field of cancer immunotherapy. They isolated human CD8+ T cells and transduced them with a lentiviral construct for a tumor antigen-specific T cell receptor (TCR) combined with the transduction enhancer LentiBOOST®. Their research shows it is feasible to transduce human T cells using a lentiviral construct in combination with LentiBOOST®. Read the paper here:

Succeed with Sirion

LentiBOOST® - Lentiviral Transduction Enhancer For Clinical Applications